Welcome to Greenshoots
Greenshoots is a collection of fresh intellectual property insight, analysis and commentary on the issues that matter most to those who invent, manage and protect intellectual property, written by the IP specialists of Appleyard Lees.
Now that you’re here, why not take a look around?
Sufficiency at the UK Supreme Court in Regeneron Pharmaceuticals Inc v Kymab Ltd
The UK Supreme Court handed down the judgment in a much anticipated biotech decision on
The Greenshoots Podcast by Appleyard Lees Episode five: Features of EPO virtual opposition hearings
Partners and patent attorneys Julia Gwilt and Bobby Smithson discuss: Features of EPO virtual opposition hearings
Drug repurposing to treat COVID-19 – practical, legal and moral implications where research involves patent-protected drugs
One of the big talking points at present is how we can get back to
Sources of funding for innovation, and innovators, in the wake of COVID-19 and beyond
Sourcing funding for innovation is currently at the forefront of many businesses’ agenda in response
The Greenshoots Podcast by Appleyard Lees Episode four: Intellectual property for start-ups in uncertain times
Patent attorneys Simon Bradbury and Parminder Lally. Simon specialises in life sciences has a particular
Akebia and Fibrogen – Lord Justice Arnold applies “Doctrine of Equivalents”
In this judgment at the High Court, Lord Justice Arnold stepped down from the Court
The Greenshoots Podcast by Appleyard Lees Episode three: Innovating & furthering a patent programme in lockdown, and priorities when returning to the lab
Appleyard Lees patent attorneys and partners Kate Hickinson and Howard Read discuss making the most of innovators’ time when
Green innovation and IP in the UK post-COVID-19: part one – green energy
The National Grid confirmed recently that the UK has completed more than a full month
Progressing innovation outside the lab: a task list for researchers during lockdown – part three, physics and engineering innovation
Lab-based scientists may not be able to access their workspace during lockdown, but there are
